FDA Approves New Treatment for Advanced Parkinson’s Disease
4 days ago · Parkinson’s disease is a condition that affects movement and gets worse over time. It happens when the brain stops making enough dopamine , a chemical that helps control things like movement ...
New Parkinson’s drug could slow or reverse progression of disease ...
Aug 21, 2024 · New Parkinson’s drug could slow or reverse progression of disease, researchers say: ‘Big step forward’. Published On. August 21, 2024. Social Media. Share this article. “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is ...
Injectable drug to ease advanced Parkinson's disease ... - Yahoo News
5 days ago · The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as Produodopa, a 24-hour infusion injected below the skin that treats motor fluctuations in patients with advanced Parkinsons.
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa
5 days ago · More than 10 million people worldwide are living with Parkinson’s disease (PD) 6, a progressive and chronic neurological disorder characterized by tremor, muscle rigidity, slowness of movement, and difficulty with balance. 5 The motor symptoms of Parkinson’s disease begin when approximately 60-80 percent of the dopamine-producing cells in ...
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...
Parkinson's News Today Home | Parkinson's News Today
5 days ago · AAV-GAD gene therapy eases Parkinson’s symptoms in early study. Treatment with the experimental gene therapy AAV-GAD led to significant easing of motor symptoms and improved life quality for most people with Parkinson’s disease in an early clinical trial, according to new data announced by the therapy’s developer MeiraGTx.
New tech could improve care for Parkinson’s patients
Sep 23, 2024 · Now, Stanford Medicine researchers have developed a simple, portable device paired with a smartphone-connected platform that patients can use at home to measure the severity of their Parkinson’s ...
New Parkinson’s Treatments in the Clinical Trial Pipeline for 2024
Sep 26, 2023 · Extensive research is underway to develop new medications for Parkinson's disease (PD), with several promising candidates at different stages of development.
Parkinson’s may take a ‘gut-first’ path — Harvard Gazette
Sep 6, 2024 · Our lab has been trying to better illuminate this ‘gut-first’ pathway of Parkinson’s disease because it can open new avenues for early intervention and treatment strategies.”. Parkinson’s disease, a progressive neurodegenerative disorder, affects an estimated 8.5 million people worldwide — a figure that has more than doubled over ...
New Findings About Key Pathological Protein in Parkinson’s Disease …
Dec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.